95 related articles for article (PubMed ID: 8786894)
1. [Epithelial dendritic cells and HIV-1 infection in vivo and in vitro].
Dezutter-Dambuyant C; Charbonnier AS; Schmitt D
Pathol Biol (Paris); 1995 Dec; 43(10):882-8. PubMed ID: 8786894
[TBL] [Abstract][Full Text] [Related]
2. [Current data on epidermal Langerhans cells].
Dezutter-Dambuyant C
Pathol Biol (Paris); 1994 Oct; 42(8):767-74. PubMed ID: 7724248
[TBL] [Abstract][Full Text] [Related]
3. [Dendritic cells of spleen and blood and HIV-1 infection].
Hosmalin A
Pathol Biol (Paris); 1995 Dec; 43(10):889-96. PubMed ID: 8786895
[TBL] [Abstract][Full Text] [Related]
4. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients.
Bhoopat L; Eiangleng L; Rugpao S; Frankel SS; Weissman D; Lekawanvijit S; Petchjom S; Thorner P; Bhoopat T
Mod Pathol; 2001 Dec; 14(12):1263-9. PubMed ID: 11743049
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells and HIV infection.
Braathen LR
Biomed Pharmacother; 1988; 42(5):305-8. PubMed ID: 3191206
[TBL] [Abstract][Full Text] [Related]
6. In vitro infection of human epidermal Langerhans' cells with HIV-1.
Ramazzotti E; Marconi A; Re MC; Girolomoni G; Cenacchi G; Vignoli M; Zambruno G; Furlini G; La Placa M; Giannetti A
Immunology; 1995 May; 85(1):94-8. PubMed ID: 7635527
[TBL] [Abstract][Full Text] [Related]
7. [Dendritic cells in dogs and cats: models of study in human pathology].
Marchal T; Saint-André I; Magnol JP; Dezutter-Dambuyant C; Schmitt D
Pathol Biol (Paris); 1995 Dec; 43(10):910-20. PubMed ID: 8786898
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous dendritic cells are main targets in acute HIV-1-infection.
Simonitsch I; Geusau A; Chott A; Jurecka W
Mod Pathol; 2000 Nov; 13(11):1232-7. PubMed ID: 11106081
[TBL] [Abstract][Full Text] [Related]
9. Epidermal and mucosal dendritic cells and HIV1 infection.
Schmitt D; Dezutter-Dambuyant C
Pathol Res Pract; 1994 Oct; 190(9-10):955-9. PubMed ID: 7899146
[TBL] [Abstract][Full Text] [Related]
10. Contribution to the regulation of virus replication in cells latently infected with human immunodeficiency virus 1.
Owatari S; Zhang J; Gao M; Tanabe-Tochikura A; Wakamiya N; Tsuchie H; Kurimura T
Acta Virol; 1997 Feb; 41(1):21-6. PubMed ID: 9199710
[TBL] [Abstract][Full Text] [Related]
11. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
12. AIDS and Langerhans cells: CD4 antigenic site density modification evidenced by single-cell immunogold labeling.
Gielen V; Schmitt D; Dezutter-Dambuyant C; Thivolet J
Reg Immunol; 1989; 2(1):7-13. PubMed ID: 2641919
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells are susceptible to measles virus infection and actively suppress T cell proliferation.
Steineur MP; Grosjean I; Bella C; Kaiserlian D
Eur J Dermatol; 1998 Sep; 8(6):413-20. PubMed ID: 9729058
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the role of oral epithelial cells and Langerhans cells as possible HIV viral reservoirs.
Boy SC; van Heerden MB; Wolfaardt M; Cockeran R; Gema E; van Heerden WF
J Oral Pathol Med; 2009 Jan; 38(1):114-9. PubMed ID: 19192056
[TBL] [Abstract][Full Text] [Related]
15. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature.
Ayala-García I; Hernández-Segura AM; Castell-Rodríguez A; Alvarez Pérez SJ; Téllez BH; Ramírez-González MD
Proc West Pharmacol Soc; 2005; 48():13-20. PubMed ID: 16416652
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.
Fehniger TA; Herbein G; Yu H; Para MI; Bernstein ZP; O'Brien WA; Caligiuri MA
J Immunol; 1998 Dec; 161(11):6433-8. PubMed ID: 9834136
[TBL] [Abstract][Full Text] [Related]
17. Macrophage HIV-1 infection and the gastrointestinal tract reservoir.
Smith PD; Meng G; Salazar-Gonzalez JF; Shaw GM
J Leukoc Biol; 2003 Nov; 74(5):642-9. PubMed ID: 12960227
[TBL] [Abstract][Full Text] [Related]
18. Virological aspects of human immunodeficiency virus infection.
Catton MG
P N G Med J; 1996 Sep; 39(3):166-73. PubMed ID: 9795557
[TBL] [Abstract][Full Text] [Related]
19. "HIV-peplotion vaccine"--a novel approach to protection against AIDS by transepithelial transport of viral peptides to Langerhans cells for long-term antiviral CTL response. (A review).
Becker Y
Acta Microbiol Immunol Hung; 1996; 43(1):1-17. PubMed ID: 8806938
[TBL] [Abstract][Full Text] [Related]
20. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
Schneider T; Ullrich R; Zeitz M
Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
